JBIO Jade Biosciences, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Jade Biosciences, Inc. (JBIO) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 6, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on July 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Jade Biosciences, Inc. (JBIO) (SEC CIK 1798749), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Jade Biosciences, Inc.
Ask AI about JBIO filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting JBIO positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on JBIO.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Jade Biosciences, Inc. (JBIO) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 1, 2026 | - | - | - |
8-K | Jun 26, 2026 | - | - | - |
8-K | Jun 11, 2026 | - | - | - |
8-K | Jun 4, 2026 | - | - | |
8-K | Jun 1, 2026 | - | - | |
8-K | May 7, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | Apr 22, 2026 | - | - | - |
8-K | Apr 2, 2026 | - | - | - |
10-K | Mar 6, 2026 | Dec 31, 2025 | - | |
8-K | Mar 6, 2026 | - | Analysis | - |
8-K | Jan 5, 2026 | - | - | |
8-K | Dec 15, 2025 | - | - | |
10-Q | Nov 14, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 13, 2025 | Jun 30, 2025 | - | |
10-Q | Apr 25, 2025 | Mar 31, 2025 | - | |
10-K | Mar 27, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 12, 2024 | Jun 30, 2024 | - | |
10-Q | May 13, 2024 | Mar 31, 2024 | - | |
10-K | Mar 25, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 9, 2024 | - | - | |
10-Q | Nov 13, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 14, 2023 | Jun 30, 2023 | - | |
10-Q | May 15, 2023 | Mar 31, 2023 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate JBIO share value held by 13F filers tracked by SignalX, by quarter.
- FMR LLC (Fidelity)+190.9K (+3%)
- Citadel Advisors LLC+101.2K (+281%)
- Millennium Management+97.2K (+155%)
- Goldman Sachs Group+87.7K (+134%)
- Renaissance Technologies LLC+65.4K (+94%)
- BlackRock556.4K (-19%)
- Wells Fargo & Co39.8K (-77%)
- Northern Trust32.2K (-12%)
- Morgan Stanley29.2K (-37%)
- BNY Mellon24.9K (-22%)
- U.S. Bancorp+15
- Vanguard Group Inc−2.10M
- Invesco Ltd−199.7K
- Ameriprise Financial−187.3K
- JPMorgan Chase & Co−20.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 62 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest JBIO SEC filings in 2026?
Jade Biosciences, Inc. (JBIO) has filed a 10-K annual report on March 6, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on July 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did JBIO file its most recent 10-K annual report?
Jade Biosciences, Inc. (JBIO) filed its most recent 10-K annual report on March 6, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view JBIO 10-Q quarterly reports?
Jade Biosciences, Inc. (JBIO)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every JBIO 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has JBIO filed recently?
Jade Biosciences, Inc. (JBIO)'s most recent 8-K was filed on July 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find JBIO insider trading activity (Form 4)?
SignalX aggregates every JBIO Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does JBIO file with the SEC?
Jade Biosciences, Inc. (JBIO) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new JBIO filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Jade Biosciences, Inc. (JBIO).
What is JBIO's SEC CIK number?
Jade Biosciences, Inc. (JBIO)'s SEC CIK (Central Index Key) number is 1798749. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1798749 to look up all JBIO filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Jade Biosciences, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 38+ filings.